- Global Pharma News & Resources

At 11.20% CAGR, Drug Discovery Informatics Market Size | Global Industry Analysis and Opportunity Assessment 2020-2025  

Pune, Maharashtra, India, December 8 2020 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Global Drug Discovery Informatics Market is valued approximately USD 1.89 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 11.20% over the forecast period 2019-2026.

Drug discovery informatics is a functional process performed by biotechnology and pharmaceutical companies that requires the generation of very large data and information. Through application of modern engineering and computational approaches the models are analyzed, visualized and simulated for pharmacological profiling. Further, rising R&D expenditure on pharmaceuticals along with the increasing government focus on drug discovery are some key forces, driving the growth of the drug discovery informatics market over the forecast period of 2019-2026. For instance: According to the U.K. government in 2016, drug development sector and continuous manufacturing would receive funds around USD 82.5 million from government and private sources as part of its new USD 188 million effort and ‘Industry Strategy’ to establish six key research hubs in UK to boost research and development activities related to drug discovery. As a result, the adoption of the drug discovery informatics would increase thereby, contributing towards the growth of the market. However, high pricing and set up cost of informatics software impede the growth of the global drug discover informatics market.

Get Sample of This Report@

Drug Discovery Informatics Market Companies

Jubilant Life Sciences IBM Infosys Thermo Fisher Scientific Perkinelmer Schrödinger Dassault Systèmes Charles River Laboratories GVK Biosciences Boehringer Ingelheim GmbH

The regional analysis of global drug discovery informatics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to well-established healthcare infrastructure along with the presence of various biotechnology and drug companies. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026 due to availability of low cost of human resources and manufacturing and availability of many qualified researchers. Also, the growth of the Asia-Pacific region is attributed owing to the ongoing drug development activities undertaken by government.

 The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below: 

By Function:
Sequencing & Target Data Analysis
Molecular Modelling
Libraries & Database Preparation
Other Functions

By Solution:

By End-User:
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROS) 
Others End Users

By Regional & Country Analysis:
North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa

Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Drug Discovery Informatics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

Table of Content

Chapter 1.    Executive Summary 
1.1.    Market Snapshot
1.2.    Key Trends
1.3.    Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Million)
1.3.1.    Drug Discovery Informatics Market, by Function, 2016-2026 (USD Million)
1.3.2.    Drug Discovery Informatics Market, by Solution , 2016-2026 (USD Million)
1.3.3.    Drug Discovery Informatics Market, by End-user 2016-2026 (USD Million)
1.3.4.    Drug Discovery Informatics Market, by Region, 2016-2026 (USD Million)
1.4.    Estimation Methodology
1.5.    Research Assumption

Chapter 2.    Global Drug Discovery Informatics Market Definition and Scope 
2.1.    Objective of the Study
2.2.    Market Definition & Scope
2.2.1.    Industry Evolution
2.2.2.    Scope of the Study
2.3.    Years Considered for the Study
2.4.    Currency Conversion Rates

Chapter 3.    Global Drug Discovery Informatics Market Dynamics    
3.1.    See Saw Analysis
3.1.1.    Market Drivers
3.1.2.    Market Challenges
3.1.3.    Market Opportunities

Chapter 4.    Global Drug Discovery Informatics Market Industry Analysis
4.1.    Porter’s 5 Force Model
4.1.1.    Bargaining Power of Buyers
4.1.2.    Bargaining Power of Suppliers
4.1.3.    Threat of New Entrants
4.1.4.    Threat of Substitutes
4.1.5.    Competitive Rivalry
4.1.6.    Futuristic Approach to Porter’s 5 Force Model
4.2.    PEST Analysis
4.2.1.    Political Scenario
4.2.2.    Economic Scenario
4.2.3.    Social Scenario
4.2.4.    Technological Scenario
4.3.    Key Buying Criteria (On Demand)
4.4.    Regulatory Framework (On Demand)
4.5.    Investment Vs Adoption Scenario (On Demand)
4.6.    Analyst Recommendation & Conclusion

Chapter 5.    Global Drug Discovery Informatics Market, by Function 

Chapter 6.    Global Drug Discovery Informatics Market, by Solution 

Chapter 7.    Global Drug Discovery Informatics Market, by End User  

Chapter 8.    Global Drug Discovery Informatics Market, by Regional Analysis

Chapter 9.    Competitive Intelligence
9.1.    Company Market Share (Subject to Data Availability)
9.2.    Top Market Strategies
9.3.    Company Profiles
9.3.1.      Jubilant Life Sciences    Overview    Financial (Subject to Data Availability)    Product Summary    Recent Developments
9.3.2.      IBM 
9.3.3.      Infosys 
9.3.4.     Thermo Fisher Scientific 
9.3.5.     Perkinelmer 
9.3.6.     Schrödinger 
9.3.7.     Dassault Systèmes 
9.3.8.      Charles River Laboratories 
9.3.9.      Selvita 


Complete Report Details @

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at





This content has been published by Brandessence Market Research and Consulting Pvt ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 08-Dec-2020